EGFR and dermatological toxicity: Furthermore, patients in the prophylactic treatment group reported improved QoL, between weeks 2 and 3 in particular, which was the median time to development of the first grade ≥2 skin toxicity in the reactive treatment group.50 The results of this study clearly support the prophylactic use of antibiotics in the management of EGFR-targeted agent-induced skin toxicity.